baber/WOPTO huggingface dataset:
Patent IL-97600-A0 (IL)
Title: Use of il-4 to enhance immune response to infectious antigenic challenges
IPC: A61K39/39
Filed: 1991-03-19
Abstract: A use of IL-4 for the manufacture of a medicament for inducing an effective immune response to endemic chronic infectious agents in a mammal exposed to such agents and a pharmaceutical composition for inducing an effective immune response to endemic chronic infectious agents in mammals exposed to such agents which compositions comprise IL-4, preferably E. coli-derived recombinant human IL-4 as an active ingredient and methods of inducing an effective immune response to endemic chronic infectious agents in mammals exposed to such agents by administering to such mammals an effective amount of IL-4, preferably recombinant human E. coli-derived IL-4 are disclosed.
Patent FI-20115718-A0 (FI)
Inventor: RIIHIMAEKI KALLE
IPC: F26B/
Filed: 2011-07-06
Abstract: .The invention relates to a method and apparatus for increasing drying efficiency and energy efficiency in connection with the dryer section in the manufacture of pulp, wherein a pulp web is conducted in the dryer section through more than one dryer device (3) and warm air is blown against the web to provide removal of moisture by evaporation, and the moisture removed from the pulp web is conducted out from the dryer section with exhaust air (2) and replacement air (1) is fed to the dryer section to replace the exhaust air (2) that has been removed. According to the invention, the exhaust air (2) including the moisture removed from the pulp web is sucked out from the dryer section, substantially from the high evaporation area (5) and from the first end (7) of the dryer section, and replacement air (1) is fed to the tail end (6) of the dryer section.
Patent IL-105124-A0 (IL)
Title: Butadiene derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C235/72
Filed: 1993-03-22
Abstract: Novel butadiene derivatives of the formula [I]: <CHEM> wherein Ring A is tri-lower alkoxyphenyl, R<1> and R<2> combine each other to form a group of the formula:     &rdurule& N-R<3>   or one of R<1> and R<2> is lower alkoxy, and the other is group of the formula: -NHR<3>, in which R<3> is hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkoxy, substituted or unsubstituted amino, hydroxy or pyridylcarbonyl, or salts thereof. Among the desired butadiene derivatives [I] of the present invention, the 3-butenoic acid-type compounds per se have antithrombotic activity, but they can also be used as an intermediate for preparing the 2,5-pyrrolidinedione-type compounds having excellent antithrombotic activity. And additionally a butenoic acid ester of the formula [II]: <CHEM> wherein Ring A is a tri-lower alkoxyphenyl group, and one of R<1><2> and R<2><2> is a lower alkoxy group, and the other is hydroxy group, or a salt thereof, as synthetic intermediate.
Patent IL-106192-A0 (IL)
Title: Preparation of 2-chloro-5-aminomethyl-pyridine
IPC: C07B61/00
Filed: 1993-06-30
Abstract: Process for the production of 2-chloro-5-aminomethylpyridine, of the formula (I), <IMAGE>  by reacting 2-chloro-5-cyanopyridine, of the formula (II), <IMAGE> with hydrogen in the presence of ammonia and in the presence of an anhydrous metal catalyst, characterised in that the reaction is carried out in an unipolar aprotic diluent at temperatures between 20 DEG C and 150 DEG C.
Patent IL-108258-A0 (IL)
Title: Piperazine derivates, their preparation and pharmaceutical compositions containing them
IPC: C07D215/40
Filed: 1994-01-03
Abstract: PCT No. PCT/GB93/02660 Sec. 371 Date May 24, 1995 Sec. 102(e) Date May 24, 1994 PCT Filed Dec. 24, 1993 PCT Pub. No. WO94/15919 PCT Pub. Date Jul. 21, 1994Piperazine derivatives of formula (I) and their pharmaceutically acceptable salts are 5-HT1A binding agents and may be used, for example, as anxiolytics. In the formula, A is an optionally substituted alkylene chain, Z is a specified bicyclic nitrogen containing heteroaromatic radical, R is hydrogen or lower alkyl, R1 is aryl or aryl(lower)alkyl and R2 and R3 are hydrogen or specified organic radicals or -NR2R3 represents a heterocyclic ring.    <IMAGE>  (I)
Patent IL-109509-A0 (IL)
Title: Transdermal system containing an indole derivative and a process for the preparation thereof
IPC: A61P43/00
Filed: 1994-05-02
Abstract: The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
Patent IL-112312-A0 (IL)
Title: Locking pliers with axial clamping action
Inventor: DAHL RAYMOND
IPC: B25B7/12
Filed: 1995-01-11
Abstract: A pair of locking pliers includes a body having a fixed jaw that supports a fixed extension. A movable jaw is pivotably mounted to the body by a hinge pin, and the movable jaw includes a movable extension. An operating lever is pivotably mounted to the movable jaw to close the movable jaw, and the movable jaw is shaped such that the movable extension slides along the fixed extension as the movable jaw is pivoted closed with the operating lever in order to provide an axial clamping action.
Patent IL-116943-A0 (IL)
Title: Substituted phenyl phenol leukotriene antagonists and intermediates thereto
IPC: C07C319/14
Filed: 1996-01-29
Abstract: Antagonists having a substituted phenyl phenol or a substituted phenolic biphenyl structure, and various derivatives thereof, are specific leukotriene antagonists.
Patent IL-119888-A0 (IL)
Title: Process for the continuous preparation of benzyl alcohol
IPC: C07C29/124
Filed: 1996-12-24
Abstract: Preparation of benzyl alcohol (BA) by high temperature hydrolysis of benzyl chloride (BCl) with water is carried out continuously by (a) feeding BCl and water in 1:(10-70) molar ratio into a reactor with dispersion equipment and reaction at 80-160 degrees C until the BCl conversion is 30-90%; (b) separating the reaction product into an aqueous and an organic phase after discharge from the reactor; (c) separating the organic phase into BCl and crude BA in a first distillation unit; (d) recycling this BCl to the reactor; (e) refining the crude BA to very pure BA in a second distillation unit, in which the by-products (especially dibenzyl ether, DB) accumulate in the sump; (f) treating the aqueous phase containing dilute hydrochloric acid (HCl) with a solvent for the organic constituents, especially benzyl alcohol, still dissolved in the dilute HCl; (g) freeing this extract from solvent in a third distillation unit and recycling it to the extractor; (h) adding the sump from the third distillation to the first to recover BA; and BA concentrating the dilute aqueous HCl from extraction in an HCl absorption unit, after removing residual organics, and passing the very pure HCl to further use or to HCl electrolysis for recovering chlorine (Cl2) for side-chain chlorination of toluene.
Patent IL-122656-A0 (IL)
Title: Therapeutic effervescent compositions
IPC: A61K9/46
Filed: 1996-06-28
Abstract: Granulates comprising an effervescent couple of anhydrous powdered monosodium citrate and powdered sodium bicarbonate and prepared using a roller compactor are formulated into pharmaceutical compositions.
Patent IL-127837-A0 (IL)
Title: Slagline sleeve for submerged entry nozzle and composition therefor
IPC: C04B35/634
Filed: 1997-07-08
Abstract: An improved submerged entry nozzle is provided which is useful in the casting of aluminum killed molten steel. The nozzle has an improved slagline sleeve or collar which surrounds the outer portion of the nozzle to protect it from corrosion during the casting process. The slagline sleeve is made from resin bonded zirconia/graphite which has been formulated so that upon curing of the resin to form resite, there is a reduction in the contractile tendency which results in a reduction in stress fracturing. The reduction of the contractile tendency and the resulting resistance to stress fracturing is achieved by adding an effective amount of calcium oxide to the resin-zirconia-graphite mixture which is used to form the sleeve.
Patent IL-130355-A0 (IL)
Title: Collarless circularly magnetized torque transducer having two phase shaft and method for measuring torque using same
IPC: G01L3/10
Filed: 1998-10-21
Abstract: A magnetoelastic torque sensor for providing an output signal indicative of the torque applied to a member about an axially extending axis of the member, comprising, a first magnetoelastically active region in the member, the region being magnetically polarized in a single circumferential direction and possessing sufficient magnetic anisotropy to return the magnetization in the region, following the application of torque to the member, to the single circumferential direction when the applied torque is reduced to zero, whereby the magnetoelastically active region produces a magnetic field varying with the torque. Magnetic field sensors are mounted proximate to the magnetoelastically active region and oriented with respect thereto to sense the magnitude of the magnetic filed at the sensors and provide the output signal in response thereto. At least the magnetoelastically active region of the member is formed of a polycrystalline material wherein at least 50 % of the distribution of local magnetizations lie within a 90°C quadrant symmetrically disposed around the single circular direction and having a coercivity sufficiently high that the field arising from the magnetoelastically active region does not magnetize regions of the member proximate to the magnetoelastically active region to give rise to parasitic magnetic fields which are of sufficient strength to destroy the usefulness, for torque sensing purposes, of the net magnetic field seen by the magnetic field sensor means.
Patent IL-138562-A0 (IL)
Title: Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses
IPC: A61K38/17
Filed: 1999-04-09
Abstract: The invention concerns a method for preparing native collagen, comprising pretreatment of the collagen in a mixer with double transverse cutters equipped with a system controlling agitating and shearing velocity and a thermostat, and a subsequent step of sterilising the collagen in liquid medium. The invention also concerns a sterile collagen, in particular a collagen mostly of type I, in native state and in particular pharmaceutical and/or parapharmaceutical and /or medico-surgical and/or ophthalmologic an/or cosmetic compositions and applications thereof.
Patent IL-145116-A0 (IL)
Title: A method and apparatus for stereoprojection of pictures
IPC: G03B35/18
Filed: 2000-03-02
Abstract: A device for stereo projection of pictures represented by a picture signal which alternates periodically between pictures intended for right eye and pictures intended for left eye. A page selector which is adapted to transmit picture signals for first and, thereupon, each odd number picture to one projector and second and, thereupon, each even number picture to another projector.
Patent IL-148412-A0 (IL)
Title: Transmission using an antenna in a cdma communication system
IPC: H04W88/08
Filed: 2000-08-17
Abstract: A receiving device comprising circuitry configured to receive a signal including pilot bits transmitted by a plurality of antennas; wherein the received signal includes data for a single user that was combined with different sequences producing a plurality of combined data sequences; wherein antenna-specific weights for the plurality of antennas are applied to each of the combined data sequences and the antenna specific weights are applied to pilot bits added with the combined data sequences; wherein the received signal includes the pilot bits for each of the plurality of antennas; and wherein the pilot bits for each antenna have a different sequence for that antenna; the circuitry is further configured to derive preferred weights for the received signal based on the pilot bits for each antenna; the circuitry is further configured to recover data for the single user from each of the combined data sequences; and the circuitry is further configured to combine data from the recovered data for the single user from each of the different sequences.
Patent IL-163808-A0 (IL)
Title: Self emulsifying drug delivery systems for poorly soluble drugs
IPC: A61K9/48
Filed: 2003-02-28
Abstract: A pharmaceutical composition in a form of a self-microemulsifying drug delivery system comprising: one or more therapeutic agent(s) which have low solubility in water or are water-insoluble, vitamin E, one co-solvent selected from propylene glycol and ethanol, one or more bile salts, TPGS, and one further surfactant selected from Tyloxapol and polyoxyl hydrogenated castor oil.
Patent IL-172048-A0 (IL)
Title: Footwear molds
IPC: A43B3/10
Filed: 2005-11-20
Abstract: Among other things, the present invention provides apparatus and methods for manufacturing footwear pieces. In various cases, the apparatus include a footwear form that includes a location mark corresponding to a location of a strap rivet. The footwear form is an inner portion of a footwear mold, and the footwear mold is comprised of an upper portion and a lower portion that substantially encompass the footwear form.
Patent IL-175561-A0 (IL)
Title: Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
IPC: A61K9/28
Filed: 2006-05-11
Abstract: The invention relates to a multilayer pharmaceutical dosage form for the controlled release of active substances, containing: a) a core layer containing a substance that acts in a modulatory manner with regard to the release of active substances, optionally a neutral core and/or an active substance; b) an inner control layer that influences the release of the substance that acts in a modulatory manner and of the optionally contained active substance from the core layer, containing pharmaceutically useable polymers, waxes, resins and/or proteins; c) an active substance layer containing a pharmaceutical active substance and, optionally, a substance that acts in a modulatory manner; d) an outer control layer containing a (meth)acrylate copolymer or a mixture consisting of a number of (meth)acrylate copolymers comprised of 98 to 85 C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl esters of (meth)acrylic acid and 2 to 15% by weight of methacrylate monomers with a quaternary ammonium group in the alkyl radical and optionally containing pharmaceutically useable polymers that are insoluble in water, whereby the layers can contain, in addition and in a known manner, pharmaceutically conventional adjuvants.
Patent IL-178604-A0 (IL)
Title: Method of controlling and analysing communications in a telephone network
IPC: H04W24/00
Filed: 2006-10-15
Abstract: The invention relates to a method and system for controlling and analyzing cellular radio communications exchanged between mobile terminals and base stations BTS. The invention is characterized in that a dummy mobile terminals and base stations BTS. The invention is comprising a dummy mobile telephone network RRTM_F comprising a dummy base station BTS_F and a dummy mobile terminal MS_F are inserted into the real network RRTM_R, said dummy network being responsible for the decoding and transparent synchronous relaying of messages exchanged between the real network and the real mobile as well as real mobile access control from the real network or the dummy network.
Patent IL-186441-A0 (IL)
Title: Methods and apparatus for encoding and decoding an highband portion of a speech signal
IPC: G10L25/90
Filed: 2007-10-07
Abstract: A wideband speech encoder according to one embodiment includes a narrowband encoder and a highband encoder. The narrowband encoder is configured to encode a narrowband portion of a wideband speech signal into a set of filter parameters and a corresponding encoded excitation signal. The highband encoder is configured to encode, according to a highband excitation signal, a highband portion of the wideband speech signal into a set of filter parameters. The highband encoder is configured to generate the highband excitation signal by applying a nonlinear function to a signal based on the encoded narrowband excitation signal to generate a spectrally extended signal.
Patent IL-189017-A0 (IL)
Title: 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents
Filed: 2008-01-24
Abstract: The invention provides compound and salts of Formula I and II, disclosed herein, which includes compounds of Formula A and Formula B: Such compounds possess useful antimicrobial activity. The variables R2, R3, R5, R6, R7, and R9 shown in Formula A and B are defined herein. Certain compounds of Formula I and Formula II disclosed herein are potent and/or selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
Patent RO-126536-A0 (RO)
Title: Portable apparatus for physiotherapy with magnetic and optical pulses in the elf frequency range
Inventor: BEŞLIU ION
IPC: A61N2/04
Filed: 2010-11-25
Abstract: The invention relates to a portable apparatus for physiotherapy with magnetic and optical pulses in the extremely low frequency range. According to the invention, the apparatus consists of a first oscillator (O) with fixed frequence, a second oscillator (O) of adjustable frequency, selectable by commutators, both being in the extremely low frequency range, an induction coil (L) which generates pulsating magnetic fields, two groups of luminescent diodes (LEDand LED) which emit light pulses of different wave lengths in the visible spectrum, a first final circuit (CF) for the control of the induction coil (L) and other two final circuits (CFand CF) for controlling the two groups of luminescent diodes (LEDand LED).
Patent RO-129889-A0 (RO)
Title: Engine with magnetic chamber
Inventor: POSTELNICU OVIDIU
IPC: F02G3/00
Filed: 2014-07-02
Abstract: The invention relates to an engine with magnetic chamber which is a new type of external combustion engine characterized by a high yield and reduced fuel consumption, intended for aircraft and spacecraft industry. According to the invention, the engine consists of an engine body () made of a magnetically insulating material which is a composite material, pig iron, aluminium or ceramics, provided with some flaps () meant to increase the outlet pressure, the fuel or fuel mixture being charged with positive charge by some magnets or electromagnets (), the fuel being supplied to the combustion chamber by a generator (), by means of some injectors () and the engine being confined by a magnetic field of positive charge created by a magnet or electromagnet (), also supplied from a generator (), the role of the magnetic field being to reject and send the fuel towards a magnet or electromagnet () which generates a magnetic field in order to attract the positively charged fuel into the ignition zone, the ignition being achieved by an electrode (), where both the electrode () and electromagnet () are supplied from the generator () and the cooling of the engine body () achieved through some cooling channels (), as well as the other auxiliary functions required for the operation of the engine with magnetic chamber, are also achieved by the generator () which can be a low-power heat engine or electric motor provided with the equipments needed for the operation of the engine with magnetic chamber.
Patent RO-131883-A0 (RO)
Title: Process and compositions for producing bio-active laminated composites (with antibacterial/antifungal/antioxidant effect) meant for food packaging
Inventor: MUNTEANU SILVESTRU BOGDANEL
IPC: D04H1/728
Filed: 2016-08-11
Abstract: The invention relates to a process for producing bio-active laminated composites to be used in food packaging industry. According to the invention, the process consists of the coaxial electro-deposition of nanoporous structures of a bio-active electro-spinning element consisting of chitosan on sublayers of plasma-pre-treated biodegradable polyesters of polylactic acid or polyhydroxybutyrate type, resulting in a laminated composite comprising chitosan nanofibers which encapsulate an active non-electro-spinning element, such as essential oils or pressed vegetable oils, having an improved antibacterial, antifungal and antioxidant activity.
Patent AP-2002002684-A0 (AP)
Title: 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
Inventor: CRAIG ANDREW SIMON
IPC: A61P3/10
Filed: 2001-06-08
Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydriodide or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
Patent MA-22815-A1 (MA)
Inventor: ETIENNE MARIA BETTY ANDRE JEUN
IPC: B01D19/04
Filed: 1993-03-05
Abstract: The present application provides suds controlling compositions, comprising a silicone antifoam agent, a carrier material, a dispersant and a polymer-based latex. The present application also provides detergent compositions containing said suds controlling compositions.
Patent MA-26953-A1 (MA)
Title: Derives de pipérazine pontés.
Inventor: LAURA COOK BLUMBERG
IPC: C07D451/02
Filed: 2003-04-08
Abstract: Dérivés de pipérazine pontés Un composé de formule (I) ou son sel pharmaceutiquement acceptable, formule dans laquelle a, c, d, k, 1, m, W, X, Y, Z, R1 et R4 répondent aux définitions, qui est utile pour le traitement de l'inflammation et d'autres troubles immunitaires. DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 19 Octobre 2000 60/241,804 Voir en annexe le titre de l'invention et le texte de l'abrégé
Patent MA-37871-A1 (MA)
Title: Dispositif d'inhalation d'aérosol
Inventor: BRAMBILLA GAETANO
IPC: A61M15/00
Filed: 2013-08-23
Abstract: L'invention concerne un actionneur (1) pour un dispositif d'inhalation d'aérosol, comprenant un boîtier conçu pour recevoir un récipient d'aérosol (2) contenant une formulation de médicament mise sous pression, une partie embout buccal à travers laquelle l'utilisateur inspire, un bloc de buse (5), un orifice (8) et un élément tubulaire (11) s'étendant dans la partie embout buccal à partir de l'ouverture d'orifice dans un axe longitudinal aligné avec un axe longitudinal de la partie embout buccal. En particulier, ledit élément tubulaire est positionné pour enfermer l'ouverture d'orifice dans un renfoncement. L'élément tubulaire est configuré de telle sorte que l'une de ses ouvertures terminales peut être ajustée étroitement sur la surface externe de bloc de buse, autour de l'ouverture d'orifice, de façon à être dans un trajet d'écoulement continu avec l'orifice. Une telle configuration confère une diminution considérable de la fraction grossière, non respirable, du médicament d'aérosol émis par l'intermédiaire d'un impact et d'une retenue inertiels dans l'actionneur plutôt que dans l'oropharynx, avec moins d'effets secondaires et de candidose orale qui en résultent chez le patient. La présence de l'élément tubulaire a un impact négligeable minime sur la dose de particules fines et sur la distribution granulométrique (psd) des particules distribuées ayant un diamètre aérodynamique inférieur à 9 µm.